Charlotte Becker

2.3k total citations
46 papers, 1.7k citations indexed

About

Charlotte Becker is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Statistics and Probability. According to data from OpenAlex, Charlotte Becker has authored 46 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 8 papers in Statistics and Probability. Recurrent topics in Charlotte Becker's work include Prostate Cancer Treatment and Research (25 papers), Prostate Cancer Diagnosis and Treatment (20 papers) and Statistical Methods in Clinical Trials (8 papers). Charlotte Becker is often cited by papers focused on Prostate Cancer Treatment and Research (25 papers), Prostate Cancer Diagnosis and Treatment (20 papers) and Statistical Methods in Clinical Trials (8 papers). Charlotte Becker collaborates with scholars based in Sweden, United States and Finland. Charlotte Becker's co-authors include Hans Lilja, Kim Pettersson, Andrew J. Vickers, Jonas Hugosson, Timo Piironen, Peter T. Scardino, Thomas Björk, David Ulmert, Göran Berglund and Angel M. Cronin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Charlotte Becker

46 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charlotte Becker Sweden	25	1.0k	355	217	216	193	46	1.7k
Debra J. Bruzek United States	16	1.1k 1.0×	321 0.9×	144 0.7×	166 0.8×	205 1.1×	34	1.4k
Mario Eisenberger United States	14	981 0.9×	234 0.7×	142 0.7×	247 1.1×	398 2.1×	32	1.5k
Sara M. Falzarano United States	18	1.2k 1.1×	524 1.5×	247 1.1×	522 2.4×	194 1.0×	55	1.7k
Deborah Bradley United States	19	792 0.8×	502 1.4×	229 1.1×	287 1.3×	378 2.0×	34	1.7k
Edgar Ben‐Josef United States	19	973 0.9×	324 0.9×	141 0.6×	176 0.8×	408 2.1×	34	1.6k
Akira Komiya Japan	29	1.4k 1.3×	943 2.7×	300 1.4×	492 2.3×	438 2.3×	99	2.4k
Isabel Heidegger Austria	26	1.2k 1.1×	829 2.3×	489 2.3×	554 2.6×	553 2.9×	123	2.4k
Philipp Nuhn Germany	21	978 0.9×	656 1.8×	367 1.7×	427 2.0×	433 2.2×	104	1.8k
Varagur Venkatesan Canada	22	1.6k 1.6×	176 0.5×	448 2.1×	453 2.1×	358 1.9×	47	2.4k
Rosina T. Lis United States	24	973 0.9×	970 2.7×	246 1.1×	678 3.1×	365 1.9×	51	2.0k

Countries citing papers authored by Charlotte Becker

Since Specialization

Citations

This map shows the geographic impact of Charlotte Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Becker more than expected).

Fields of papers citing papers by Charlotte Becker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Becker. The network helps show where Charlotte Becker may publish in the future.

Co-authorship network of co-authors of Charlotte Becker

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte Becker. A scholar is included among the top collaborators of Charlotte Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte Becker. Charlotte Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hammarsten, Ola, et al.. (2023). Methods for analyzing positive cardiac troponin assay interference. Clinical Biochemistry. 116. 24–30. 14 indexed citations

Ankarberg‐Lindgren, Carina, et al.. (2023). Methodological considerations in determining sex steroids in children: comparison of conventional immunoassays with liquid chromatography-tandem mass spectrometry. Clinical Chemistry and Laboratory Medicine (CCLM). 62(1). 85–96. 11 indexed citations

Becker, Charlotte, Anne‐Greth Bondeson, Lennart Bondeson, et al.. (2012). Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk. International Journal of Cancer. 131(9). 2126–2133. 67 indexed citations

Johansson, Jesper, et al.. (2010). C-peptide in dried blood spots. Scandinavian Journal of Clinical and Laboratory Investigation. 70(6). 404–409. 10 indexed citations

Vickers, Andrew J., Angel M. Cronin, Gunnar Aus, et al.. (2010). Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate‐specific antigen. Cancer. 116(11). 2612–2620. 58 indexed citations

Schwenk, Jochen M., Maja Neiman, Hanno Langen, et al.. (2010). Toward Next Generation Plasma Profiling via Heat-induced Epitope Retrieval and Array-based Assays. Molecular & Cellular Proteomics. 9(11). 2497–2507. 54 indexed citations

Ulmert, David, Angel M. Cronin, Thomas Björk, et al.. (2008). Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study. BMC Medicine. 6(1). 6–6. 83 indexed citations

Vickers, Andrew J., Angel M. Cronin, Gunnar Aus, et al.. (2008). A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden. BMC Medicine. 6(1). 19–19. 190 indexed citations

Almqvist, Erik G., Charlotte Becker, Anne‐Greth Bondeson, et al.. (2006). Increased plasma concentrations of N‐terminal pro‐B‐type natriuretic peptide in patients with mild primary hyperparathyroidism. Clinical Endocrinology. 65(6). 760–766. 7 indexed citations

10.

Steuber, Thomas, Andrew J. Vickers, Alexander Haese, et al.. (2005). Risk assessment for biochemical recurrence prior to radical prostatectomy: Significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA‐elevation in serum. International Journal of Cancer. 118(5). 1234–1240. 37 indexed citations

11.

Becker, Charlotte, et al.. (2005). Assessment of intra‐individual variation in prostate‐specific antigen levels in a biennial randomized prostate cancer screening program in Sweden. The Prostate. 65(3). 216–221. 24 indexed citations

12.

Almqvist, Erik G., Charlotte Becker, Anne‐Greth Bondeson, Lennart Bondeson, & Johan Svensson. (2004). Early parathyroidectomy increases bone mineral density in patients with mild primary hyperparathyroidism: A prospective and randomized study. Surgery. 136(6). 1281–1288. 58 indexed citations

13.

Ekström, Simon, Lars Wallman, Johan Malm, et al.. (2004). Integrated selective enrichment target – a microtechnology platform for matrix‐assisted laser desorption/ionization‐mass spectrometry applied on protein biomarkers in prostate diseases. Electrophoresis. 25(21-22). 3769–3777. 34 indexed citations

14.

Aus, Gunnar, Charlotte Becker, Stefan Franzén, et al.. (2003). Cumulative Prostate Cancer Risk Assessment with the Aid of the Free-to-Total Prostate Specific Antigen Ratio. European Urology. 45(2). 160–165. 20 indexed citations

15.

Cao, Yue, Charlotte Becker, Åke Lundwall, et al.. (2003). Expression of protein C inhibitor (PCI) in benign and malignant prostatic tissues. The Prostate. 57(3). 196–204. 28 indexed citations

16.

Haese, Alexander, Markus Graefen, Thomas Steuber, et al.. (2001). Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ‐confined from locally‐advanced prostate cancer in total PSA‐levels below 10 ng/ml. The Prostate. 49(2). 101–109. 66 indexed citations

17.

Becker, Charlotte, Timo Piironen, Kim Pettersson, Jonas Hugosson, & Hans Lilja. (2000). Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater. Urology. 55(5). 694–699. 61 indexed citations

18.

Törnblom, Magnus, Ulf Norming, Jan Adolfsson, et al.. (1999). Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL. Urology. 53(5). 945–950. 33 indexed citations

19.

Kruger, Arto E. Boeken, Fritz H. Schröder, C. Thomas, et al.. (1999). SENSITIVE AND SPECIFIC ASSAY OF HUMAN KALLIKREIN 2 (hK2) IN SERUM IMPROVES PROSTATE CANCER DIAGNOSIS. The Journal of Urology. 317–317. 3 indexed citations

20.

Piironen, Timo, Bruno O. Villoutreix, Charlotte Becker, et al.. (1998). Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling. Protein Science. 7(2). 259–269. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact